What is the Hydrus® Microstent and why is it effective in glaucoma treatment? | EYE NEWS TV скачать в хорошем качестве

What is the Hydrus® Microstent and why is it effective in glaucoma treatment? | EYE NEWS TV

Nathan M. Radcliffe, MD, is a board-certified ophthalmologist who specializes in glaucoma and cataract surgery. Dr. Radcliffe is regarded as a leader in the field of Glaucoma, more specifically in the innovations of minimally invasive, “microincisional”, glaucoma surgery. He has been recognized as a rising star, and was recognized as a “Top 40 Ophthalmologist Under 40” by The Ophthalmologist journal. Dr. Radcliffe has published over 40 peer-reviewed publications in glaucoma research. He is committed to teaching others, from residents to experienced surgeons alike, and has given hundreds of lectures to thousands of ophthalmologists in 40 states and over a dozen different countries. He has won awards for his surgical videos and teaching, including the NYU Residents Teaching Award in 2015. Roughly the size of an eyelash, the highly flexible Hydrus Microstent is placed by a doctor using microscopic incisions and advanced equipment. This less invasive approach allows for fewer complications and faster healing times than traditional glaucoma surgery. What is the Ivantis Hydrus® Microstent? The Hydrus Microstent is a small (the size of one eyelash), flexible device made of a biocompatible alloy of nickel and titanium (nitinol®) designed to be inserted into the trabecular meshwork and Schlemm’s canal using a unique delivery system. It functions as an “intracanalicular scaffold” to facilitate aqueous drainage from the anterior chamber. Eye News TV provides eye care education for both doctors and patients. Content creator, Tom Pace interviews ophthalmologists/optometrists and patients about the latest eye technology, customer experience, and patient outcomes. Other channels include Dry Eye News TV, Retina News TV, Glaucoma News TV, Cataract News TV.